ホーム > 石毛 和紀/ Ishige, Kazunori

石毛 和紀

ALUMNI 2025年3月現在、筑波大学が主たる所属機関ではありません

Ishige, Kazunori

医学医療系 , 講師
Faculty of Medicine , Assistant Professor
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease Takashi Shida; Kentaro Akiyama; Sechang Oh; Akemi Sawai (+8 著者) Junichi Shoda
      Journal of Gastroenterology 53: 535 (2018) Semantic Scholar
  2. 2. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis Kentaro Akiyama; Eiji Warabi; Kosuke Okada; Toru Yanagawa (+9 著者) Junichi Shoda
      Experimental Animals 67: 201 (2018) Semantic Scholar
  3. 3. Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal muscles Sechang Oh; Shoichi Komine; Eiji Warabi; Kentaro Akiyama (+8 著者) Junichi Shoda
      SCIENTIFIC REPORTS 7: 12902 (2017) Semantic Scholar
  4. 4. Exercise training enhances in vivo clearance of endotoxin and attenuates inflammatory responses by potentiating Kupffer cell phagocytosis Shoichi Komine; Kentaro Akiyama; Eiji Warabi; Sechang Oh (+4 著者) Junichi Shoda
      SCIENTIFIC REPORTS 7: 11977 (2017) Semantic Scholar
  5. 5. An autopsy case of non-traumatic fat embolism syndrome Mai Sakashita; Shingo Sakashita; Akiko Sakata; Noriko Uesugi (+2 著者) Masayuki Noguchi
      PATHOLOGY INTERNATIONAL 67: 477 (2017) Semantic Scholar
  6. 6. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma Kuniaki Fukuda; Toshiyuki Okumura; Masato Abei; Nobuyoshi Fukumitsu (+8 著者) Ichinosuke Hyodo
      Cancer Science 108: 497 (2017) Semantic Scholar
  7. 7. Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response. Yuki Inagaki; Yukio Oshiro; Mamiko Imanishi; Kazunori Ishige (+2 著者) Nobuhiro Ohkohchi
      Clinical journal of gastroenterology 8: 247 (2015) Semantic Scholar
  8. 8. Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients. Suzuki H; Roa JC; Kawamoto T; Ishige K (+3 著者) Shoda J
      Molecular and clinical oncology 3: 464 (2015) Semantic Scholar
  9. 9. Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima (+5 著者) Junichi Shoda
      JOURNAL OF GASTROENTEROLOGY 50: 467 (2015) Semantic Scholar
  10. 10. Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status Toshikazu Moriwaki; Kazunori Ishige; Masahiro Araki; Shigemasa Yoshida (+10 著者) Ichinosuke Hyodo
      MEDICAL ONCOLOGY 31: 287 (2014) Semantic Scholar
  11. 11. Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder Kenichiro Onuki; Hiroaki Sugiyama; Kazunori Ishige; Toru Kawamoto (+10 著者) Junichi Shoda
      JOURNAL OF GASTROENTEROLOGY 49: 702 (2014) Semantic Scholar
  12. 12. A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma Masato Abei; Toshiyuki Okumura; Kuniaki Fukuda; Takayuki Hashimoto (+13 著者) Koji Tsuboi
      Radiation Oncology 8: 239 (2013) Semantic Scholar
  13. 13. Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma. Seto K; Shoda J; Horibe T; Warabi E (+5 著者) Kawakami K
      ONCOLOGY REPORTS 29: 2147 (2013) Semantic Scholar
  14. 14. Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options Junichi Shoda; Kazunori Ishige; Hiroaki Sugiyama; Toru Kawamoto
      JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 19: 342 (2012) Semantic Scholar
  15. 15. Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy Masato Kishida; Kazunori Ishige; Tomohisa Horibe; Noriko Tada (+3 著者) Koji Kawakami
      ONCOLOGY LETTERS 3: 525 (2012) Semantic Scholar
  16. 16. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells Hiroaki Sugiyama; Kenichiro Onuki; Kazunori Ishige; Nobue Baba (+8 著者) Junichi Shoda
      JOURNAL OF GASTROENTEROLOGY 46: 779 (2011) Semantic Scholar
  17. 17. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice Hirokazu Sugimoto; Kosuke Okada; Junichi Shoda; Eiji Warabi (+7 著者) Masayuki Yamamoto
      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY 298: G283 (2010) Semantic Scholar
  18. 18. Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma Kazunori Ishige; Junichi Shoda; Toru Kawamoto; Sachiko Matsuda (+4 著者) Koji Kawakami
      INTERNATIONAL JOURNAL OF CANCER 123: 2915 (2008) Semantic Scholar
  19. 19. MUC4 interacts with ErbB2 in human gallbladder carcinoma: Potential pathobiological implications Naoki Miyahara; Junichi Shoda; Kazunori Ishige; Toru Kawamoto (+7 著者) Tatsuro Irimura
      EUROPEAN JOURNAL OF CANCER 44: 1048 (2008) Semantic Scholar
  20. 20. Hypointense gallbladder on MR cholangiopancreatography. Ishige K; Okada K; Kikuchi N; Satoh H
      Hepato-gastroenterology 55: 333 (2008)

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

 227 total views